Cell Counting Kit-8 (CCK-8): Sensitive, WST-8-Based Cell Viability Assay

Executive Summary: Cell Counting Kit-8 (CCK-8) employs WST-8, a water-soluble tetrazolium salt, to quantify live cell numbers by detecting mitochondrial dehydrogenase activity. Its product, a water-soluble formazan dye, enables direct, high-sensitivity measurement of cell viability (Li et al., 2025, DOI). CCK-8 is superior to MTT/XTT/MTS/WST-1 in workflow simplicity and does not require organic solvents or additional processing steps (product page). This assay is validated in cancer research, toxicology, and nephrotoxicity studies, offering reproducibility and compatibility with high-throughput screening. The CCK-8 kit (K1018) is widely adopted for cytotoxicity, proliferation, and metabolic activity assessments in biomedical research.

Biological Rationale

Quantifying cell viability is essential in cell biology, toxicology, and pharmacology. Cell proliferation and cytotoxicity assays enable researchers to assess drug efficacy, toxic agent effects, and basic cellular physiology. Mitochondrial dehydrogenases are ubiquitous enzymes in viable cells, making them reliable markers for cell viability. Traditional assays (e.g., MTT, XTT) rely on tetrazolium salt reduction but have drawbacks such as insoluble end-products, lower sensitivity, and labor-intensive protocols (Amyloid-protein-1-15.com article). CCK-8 leverages WST-8, which is reduced by living cells to yield a water-soluble formazan, allowing direct and quantitative detection of viable cells without solubilization steps.

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

CCK-8 utilizes WST-8, a water-soluble tetrazolium salt. In the presence of electron mediators, mitochondrial dehydrogenases in viable cells reduce WST-8 to a formazan dye. The amount of formazan produced is directly proportional to the number of metabolically active cells. The water solubility of WST-8’s formazan product enables direct absorbance measurement at 450 nm using a microplate reader (Cell Counting Kit-8 (CCK-8) product page). This contrasts with the MTT assay, where the formazan product is insoluble and requires dissolution in DMSO or acidified isopropanol. The CCK-8 reaction is non-toxic, enabling longitudinal or repeat measurements in the same culture.

Evidence & Benchmarks

• CCK-8 provides a linear correlation (R² > 0.99) between absorbance at 450 nm and viable cell number in HK2 and other mammalian cell lines (Li et al., 2025, DOI).
• In nephrotoxicity models, CCK-8 reliably detects reductions in cell viability following CdCl2 exposure and restoration after antioxidant intervention (Li et al., 2025, DOI).
• Compared to MTT, XTT, and WST-1, CCK-8 demonstrates greater sensitivity and eliminates the need for solubilization, reducing hands-on time by 30–50% (product documentation, ApexBio).
• CCK-8 is compatible with a wide range of cell types, including primary, immortalized, and stem cells (Angiotensin-1-2-1-9.com article).
• Formazan product from CCK-8 is stable for at least 12 hours at room temperature, minimizing readout variability (ApexBio).

Applications, Limits & Misconceptions

CCK-8 is a gold standard for in vitro cell proliferation, cytotoxicity, and metabolic activity measurement. The assay is widely used in cancer research, assessment of nephrotoxicity, environmental toxicology, neurodegenerative disease models, and high-throughput drug screening (related article). This article extends the mechanistic discussion of CCK-8’s application from tumor microenvironment studies to oxidative stress/nephrotoxicity models.

For an in-depth mechanistic review on integrating CCK-8 with apoptosis and signaling pathway analysis, see this article; here, we focus on nephrotoxicity and sensitivity benchmarks.

Common Pitfalls or Misconceptions

• Non-viable cells do not reduce WST-8: The assay cannot distinguish between different types of cell death or causes of metabolic inactivity.
• Interference by reducing agents: Compounds with strong reducing properties (e.g., ascorbate, DTT) in test media can artificially increase absorbance.
• Confluent cultures: Overly dense cultures may plateau, masking subtle treatment effects.
• Inapplicability to in vivo studies: CCK-8 is for in vitro use only; it cannot be used to directly assess tissue viability in whole organisms.
• Enzyme inhibitors: Agents that non-specifically inhibit mitochondrial or cytosolic dehydrogenases may confound results unrelated to cell viability.

Workflow Integration & Parameters

CCK-8 is provided as a ready-to-use reagent. After seeding cells in a 96-well plate (typically 1–10 × 10³ cells/well), cells are treated with test compounds and incubated under standard conditions (e.g., 37°C, 5% CO₂). At the desired time point, 10 μL of CCK-8 reagent is added to each well containing 100 μL culture medium. Plates are incubated for 1–4 hours, and absorbance is measured at 450 nm. No washing or solubilization is required. The protocol is amenable to automation and high-throughput screening platforms (ApexBio).

For best practices and advanced applications in environmental toxicology and ferroptosis studies, see this article; here, we provide updated nephrotoxicity and workflow integration benchmarks.

Conclusion & Outlook

The Cell Counting Kit-8 (CCK-8), leveraging the WST-8 substrate, is a robust, sensitive, and user-friendly assay for cell viability, proliferation, and cytotoxicity measurement. Its advantages over classical tetrazolium salt-based methods include higher sensitivity, direct readout, and simplified workflow. CCK-8 is validated in recent nephrotoxicity and oxidative stress studies, such as those modeling cadmium-induced kidney injury (Li et al., 2025, DOI). As high-throughput and precision toxicology demands increase, CCK-8 remains a cornerstone technology for quantitative cell-based assays in biomedical research.